Dawid Gruszczynski
Overview
Explore the profile of Dawid Gruszczynski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sawicka-Gutaj N, Stanska A, Stanski M, Gruszczynski D, Zawalna N, Pochylski M, et al.
Graefes Arch Clin Exp Ophthalmol
. 2025 Jan;
PMID: 39751637
Purpose: Graves' disease (GD) and Graves' orbitopathy (GO) are multifactorial disorders with links to the gut microbiome and autoimmunity. It is observed that patients with GD exhibit altered gut microbiome...
2.
Sawicka-Gutaj N, Gruszczynski D, Zawalna N, Nijakowski K, Fichna M, Ruchala M
Pol Arch Intern Med
. 2024 Jun;
134(6).
PMID: 38856675
No abstract available.
3.
Nijakowski K, Rutkowski R, Gruszczynski D, Witowski J, Surdacka A, Kanikowska D
Front Biosci (Landmark Ed)
. 2024 Jan;
29(1):10.
PMID: 38287829
Background: The interaction between oxidative status markers and biological rhythms is considered particularly important in the pathogenesis of many diseases and more effective therapies. We aimed to determine if the...
4.
Sawicka-Gutaj N, Gruszczynski D, Zawalna N, Nijakowski K, Skiba A, Pochylski M, et al.
Pharmacol Rep
. 2024 Jan;
76(1):185-194.
PMID: 38273183
Background: Graves' orbitopathy (GO) is an autoimmune disorder of the orbit and retro-ocular tissues and the primary extrathyroidal manifestation of Graves' disease. In moderate-to-severe and active GO iv glucocorticoids (GCs)...
5.
Nijakowski K, Jankowski J, Gruszczynski D, Surdacka A
J Clin Med
. 2023 Oct;
12(19).
PMID: 37834805
Both eating disorders and dental erosion are increasingly affecting adolescents and young adults. Thus, our systematic review was designed to answer the question: "Is there a relationship between dental erosion...
6.
Nijakowski K, Jankowski J, Gruszczynski D, Surdacka A
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569455
Salivary myeloperoxidase (MPO) is a key mediator of the oral immune system, acting as an enzyme that utilises HO to generate molecules with high bactericidal activity. While MPO determination in...
7.
Ortarzewska M, Nijakowski K, Kolasinska J, Gruszczynski D, Ruchala M, Lehmann A, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(6).
PMID: 36981758
Autoimmune thyroid disease (AITD) is a dysregulation of the immune system that causes an attack on the thyroid gland. Two major clinical manifestations are Hashimoto's thyroiditis and Graves' disease. Saliva...
8.
Nijakowski K, Zdrojewski J, Nowak M, Gruszczynski D, Knoll F, Surdacka A
Metabolites
. 2023 Jan;
13(1).
PMID: 36676953
Cancers are the leading cause of death worldwide. The most common cancers include breast, lung, and colorectum. Salivary metabolome profiling is a novel non-invasive method in oncological diagnosis. This systematic...
9.
Sawicka-Gutaj N, Gruszczynski D, Zawalna N, Nijakowski K, Muller I, Karpinski T, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362236
Autoimmune thyroid diseases (AITDs) are chronic autoimmune disorders that cause impaired immunoregulation, leading to specific immune responses against thyroid antigens. Graves' disease (GD) and Hashimoto's thyroiditis (HT) are the major...
10.
Sawicka-Gutaj N, Komarowska H, Gruszczynski D, Derwich A, Klimont A, Ruchala M
J Clin Med
. 2022 Oct;
11(19).
PMID: 36233428
Adrenocortical carcinomas (ACC) are rare endocrine malignancies, often with a poor prognosis. Visfatin/NAMPT regulates a variety of signaling pathway components, and its overexpression has been found in carcinogenesis. Our study...